Table 3

Changes from baseline in SGRQ total and domain scores at week 52 and corresponding effect sizes by changes in FVC >10% predicted and PGI-C at week 52

Change from baseline in SGRQ score at week 52Deterioration in FVC >10% predicted at week 52Improvement in FVC >10% predicted at week 52Mean (SD) differenceP valuesPGI-C score
1–2 (very much or much better) at week 52
PGI-C score
6–7 (much or very much worse) at week 52
Mean (SD) differenceP-values
nMean (SD)Effect sizenMean (SD)Effect sizenMean (SD)Effect sizenMean (SD)Effect size
Total15213.1
(15.6)
0.6421−6.8 (15.2)−0.3519.9 (3.6)<0.0001116−9.7
(14.9)
−0.557320.4
(16.6)
1.20−30.1 (2.3)<0.0001
Activity domain15415.6
(19.0)
0.6822−4.4 (17.2)−0.2219.9 (4.3)<0.0001118−7.5
(17.6)
−0.377320.8
(20.8)
1.11−28.3 (2.8)<0.0001
Impact domain15313.2
(18.1)
0.5821−9.0 (18.2)−0.4122.1 (4.2)<0.0001116−10.6 (18.3)−0.547321.4
(18.3)
1.12−32.0 (2.7)<0.0001
Symptoms domain1559.4
(20.5)
0.3822−3.2 (20.6)−0.1412.6 (4.7)0.0076118−9.1
(18.7)
−0.437417.8
(21.4)
0.92−27.0 (2.9)<0.0001
  • FVC, forced vital capacity; PGI-C, Patient ’s Global Impression of Change; SGRQ, St George’s Respiratory Questionnaire.